+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 9d98 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| タイトル | Cryo-EM structure of HIV-1 BG505 SOSIP.664 Env bound to 3-sCD4, 3-VRC34.01 Fab with two gp120 protomers rotated, Population 5 | ||||||||||||||||||||||||
要素 |
| ||||||||||||||||||||||||
キーワード | VIRAL PROTEIN/IMMUNE SYSTEM / Recombinant protein / HIV-1 Env / CD4 / fusion peptide binning antibody VRC34.01 / Vaccine / VIRAL PROTEIN / VIRAL PROTEIN-IMMUNE SYSTEM complex | ||||||||||||||||||||||||
| 機能・相同性 | 機能・相同性情報helper T cell enhancement of adaptive immune response / interleukin-16 binding / interleukin-16 receptor activity / response to methamphetamine hydrochloride / maintenance of protein location in cell / cellular response to ionomycin / T cell selection / MHC class II protein binding / positive regulation of kinase activity / interleukin-15-mediated signaling pathway ...helper T cell enhancement of adaptive immune response / interleukin-16 binding / interleukin-16 receptor activity / response to methamphetamine hydrochloride / maintenance of protein location in cell / cellular response to ionomycin / T cell selection / MHC class II protein binding / positive regulation of kinase activity / interleukin-15-mediated signaling pathway / cellular response to granulocyte macrophage colony-stimulating factor stimulus / positive regulation of monocyte differentiation / Nef Mediated CD4 Down-regulation / Alpha-defensins / regulation of T cell activation / response to vitamin D / extracellular matrix structural constituent / Other interleukin signaling / T cell receptor complex / enzyme-linked receptor protein signaling pathway / Translocation of ZAP-70 to Immunological synapse / Phosphorylation of CD3 and TCR zeta chains / positive regulation of protein kinase activity / regulation of calcium ion transport / positive regulation of calcium ion transport into cytosol / macrophage differentiation / Generation of second messenger molecules / immunoglobulin binding / T cell differentiation / Co-inhibition by PD-1 / Binding and entry of HIV virion / coreceptor activity / positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / positive regulation of T cell proliferation / positive regulation of interleukin-2 production / positive regulation of calcium-mediated signaling / cell surface receptor protein tyrosine kinase signaling pathway / protein tyrosine kinase binding / host cell endosome membrane / Vpu mediated degradation of CD4 / clathrin-coated endocytic vesicle membrane / calcium-mediated signaling / positive regulation of protein phosphorylation / MHC class II protein complex binding / transmembrane signaling receptor activity / Downstream TCR signaling / response to estradiol / Cargo recognition for clathrin-mediated endocytosis / signaling receptor activity / Clathrin-mediated endocytosis / virus receptor activity / response to ethanol / defense response to Gram-negative bacterium / clathrin-dependent endocytosis of virus by host cell / adaptive immune response / positive regulation of viral entry into host cell / early endosome / cell surface receptor signaling pathway / positive regulation of ERK1 and ERK2 cascade / positive regulation of canonical NF-kappaB signal transduction / cell adhesion / positive regulation of MAPK cascade / viral protein processing / immune response / membrane raft / endoplasmic reticulum lumen / fusion of virus membrane with host plasma membrane / external side of plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / lipid binding / symbiont entry into host cell / endoplasmic reticulum membrane / protein kinase binding / positive regulation of DNA-templated transcription / virion attachment to host cell / host cell plasma membrane / virion membrane / structural molecule activity / enzyme binding / signal transduction / protein homodimerization activity / zinc ion binding / identical protein binding / membrane / plasma membrane 類似検索 - 分子機能 | ||||||||||||||||||||||||
| 生物種 | ![]() Human immunodeficiency virus 1 (ヒト免疫不全ウイルス) Homo sapiens (ヒト) | ||||||||||||||||||||||||
| 手法 | 電子顕微鏡法 / 単粒子再構成法 / クライオ電子顕微鏡法 / 解像度: 4.19 Å | ||||||||||||||||||||||||
データ登録者 | Thakur, B. / Acharya, P. | ||||||||||||||||||||||||
| 資金援助 | 米国, 2件
| ||||||||||||||||||||||||
引用 | ジャーナル: Nat Commun / 年: 2025タイトル: Conformational trajectory of the HIV-1 fusion peptide during CD4-induced envelope opening. 著者: Bhishem Thakur / Revansiddha H Katte / Wang Xu / Katarzyna Janowska / Salam Sammour / Rory Henderson / Maolin Lu / Peter D Kwong / Priyamvada Acharya / ![]() 要旨: The hydrophobic fusion peptide (FP), a critical component of the HIV-1 entry machinery, is located at the N terminus of the envelope (Env) gp41 subunit. The receptor-binding gp120 subunit of Env ...The hydrophobic fusion peptide (FP), a critical component of the HIV-1 entry machinery, is located at the N terminus of the envelope (Env) gp41 subunit. The receptor-binding gp120 subunit of Env forms a heterodimer with gp41. The gp120/gp41 heterodimer assembles into a homotrimer, in which FP is accessible for antibody binding. Env conformational changes or "opening" that follow receptor binding result in FP relocating to a newly formed interprotomer pocket at the gp41-gp120 interface where it is sterically inaccessible to antibodies. The mechanistic steps connecting the entry-related transition of antibody accessible-to-inaccessible FP configurations remain unresolved. Here, using SOSIP-stabilized Env ectodomains, we visualize that the FP remains accessible for antibody binding despite substantial receptor-induced Env opening. We delineate stepwise Env opening from its closed state to a functional CD4-bound symmetrically open Env in which we show that FP was accessible for antibody binding. We define downstream re-organizations that lead to the formation of a gp120/gp41 cavity into which the FP buries to become inaccessible for antibody binding. These findings improve our understanding of HIV-1 entry and delineate the entry-related conformational trajectory of a key site of HIV vulnerability to neutralizing antibody. | ||||||||||||||||||||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 9d98.cif.gz | 447.3 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb9d98.ent.gz | 355.7 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 9d98.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| 文書・要旨 | 9d98_validation.pdf.gz | 1.7 MB | 表示 | wwPDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | 9d98_full_validation.pdf.gz | 1.7 MB | 表示 | |
| XML形式データ | 9d98_validation.xml.gz | 78 KB | 表示 | |
| CIF形式データ | 9d98_validation.cif.gz | 120.4 KB | 表示 | |
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/d9/9d98 ftp://data.pdbj.org/pub/pdb/validation_reports/d9/9d98 | HTTPS FTP |
-関連構造データ
| 関連構造データ | ![]() 46670MC ![]() 9d8yC ![]() 9d90C C: 同じ文献を引用 ( M: このデータのモデリングに利用したマップデータ |
|---|---|
| 類似構造データ | 類似検索 - 機能・相同性 F&H 検索 |
-
リンク
-
集合体
| 登録構造単位 | ![]()
|
|---|---|
| 1 |
|
-
要素
-タンパク質 , 3種, 9分子 ABCDEFMNO
| #1: タンパク質 | 分子量: 52508.406 Da / 分子数: 3 / 変異: T332N, A501C / 由来タイプ: 組換発現 / 詳細: BG505 SOSIP.664 construct 由来: (組換発現) ![]() Human immunodeficiency virus 1 (ヒト免疫不全ウイルス)遺伝子: env / 発現宿主: Mammalia (両生類) / 参照: UniProt: Q2N0S5 #2: タンパク質 | 分子量: 17146.482 Da / 分子数: 3 / 変異: I559P, T605C / 由来タイプ: 組換発現 / 詳細: BG505 SOSIP.664 construct 由来: (組換発現) ![]() Human immunodeficiency virus 1 (ヒト免疫不全ウイルス)遺伝子: env / 発現宿主: Mammalia (両生類) / 参照: UniProt: Q2N0S5 #5: タンパク質 | 分子量: 20129.896 Da / 分子数: 3 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: CD4 / 発現宿主: Mammalia (両生類) / 参照: UniProt: P01730 |
|---|
-抗体 , 2種, 6分子 GIKHJL
| #3: 抗体 | 分子量: 23797.615 Da / 分子数: 3 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 発現宿主: Mammalia (両生類)#4: 抗体 | 分子量: 23138.766 Da / 分子数: 3 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 発現宿主: Mammalia (両生類) |
|---|
-糖 , 3種, 3分子
| #6: 多糖 | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D- ...alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose |
|---|---|
| #7: 多糖 | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta- ...beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose |
| #8: 多糖 | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2- ...alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose |
-詳細
| 研究の焦点であるリガンドがあるか | Y |
|---|---|
| Has protein modification | Y |
-実験情報
-実験
| 実験 | 手法: 電子顕微鏡法 |
|---|---|
| EM実験 | 試料の集合状態: PARTICLE / 3次元再構成法: 単粒子再構成法 |
-
試料調製
| 構成要素 |
| |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 分子量 | 値: 0.308 MDa / 実験値: NO | |||||||||||||||||||||||||||||||||||
| 由来(天然) |
| |||||||||||||||||||||||||||||||||||
| 由来(組換発現) |
| |||||||||||||||||||||||||||||||||||
| 緩衝液 | pH: 8 | |||||||||||||||||||||||||||||||||||
| 試料 | 包埋: NO / シャドウイング: NO / 染色: NO / 凍結: YES | |||||||||||||||||||||||||||||||||||
| 試料支持 | グリッドの材料: COPPER / グリッドのサイズ: 300 divisions/in. / グリッドのタイプ: Quantifoil R1.2/1.3 | |||||||||||||||||||||||||||||||||||
| 急速凍結 | 装置: LEICA EM GP / 凍結剤: ETHANE / 湿度: 95 % / 凍結前の試料温度: 295 K |
-
電子顕微鏡撮影
| 実験機器 | ![]() モデル: Titan Krios / 画像提供: FEI Company |
|---|---|
| 顕微鏡 | モデル: TFS KRIOS |
| 電子銃 | 電子線源: FIELD EMISSION GUN / 加速電圧: 300 kV / 照射モード: FLOOD BEAM |
| 電子レンズ | モード: BRIGHT FIELD / 最大 デフォーカス(公称値): 2400 nm / 最小 デフォーカス(公称値): 800 nm |
| 撮影 | 電子線照射量: 60.9 e/Å2 / フィルム・検出器のモデル: GATAN K3 (6k x 4k) |
-
解析
| EMソフトウェア |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF補正 | タイプ: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| 粒子像の選択 | 選択した粒子像数: 998476 | ||||||||||||||||||||||||
| 3次元再構成 | 解像度: 4.19 Å / 解像度の算出法: FSC 0.143 CUT-OFF / 粒子像の数: 138204 / 対称性のタイプ: POINT | ||||||||||||||||||||||||
| 原子モデル構築 | 空間: REAL | ||||||||||||||||||||||||
| 精密化 | 最高解像度: 4.19 Å 立体化学のターゲット値: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||
| 拘束条件 |
|
ムービー
コントローラー
万見について





Human immunodeficiency virus 1 (ヒト免疫不全ウイルス)
Homo sapiens (ヒト)
米国, 2件
引用






PDBj






















FIELD EMISSION GUN